Intelliject gets $15m debt injection for pipeline
This article was originally published in Scrip
Executive Summary
The private speciality pharmaceutical company Intelliject has agreed a $15 million debt facility with Hercules Technology Growth Capital to fund the acceleration of its key pipeline products.